Quantitative approaches to drug development

Quantitative approaches to drug development

We provide consultancy services to help our clients reduce uncertainty in research and regulatory questions, increasing confidence in the development of new medicines that can improve patients’ lives.

Science and Services



Pharmetheus evolves its organization to further promote innovation and growth with additions to its leadership team

– These changes are natural progressions towards our long-term strategy. Our leadership team is broadening its competencies and perspectives, reinforcing Pharmetheus’ positioning as an important contributor in the advancement of quantitative disciplines, ensuring continued growth and success for our sector within the industry, says Peter Milligan, CEO. As part of this transition, Pharmetheus announces the addition of key leaders to…

Pharmetheus strengthens board of directors with key appointments

Joining the board are Sverre Bengtsson and Marie Sandström, both bringing extensive experience and invaluable insights to the Pharmetheus Board of Directors. Sverre Bengtsson, renowned for his product development acumen as founder at Viedoc, joins as a board member, strengthening the company’s strategic direction with his deep understanding of product innovation and commercialization. Sverre Bengtsson comments on his appointment: –…

New Publication: Bioavailability of three novel oral, sustained-release pellets, relative to an immediate-release tablet containing 500 mg flucytosine: A randomized, open-label, crossover study in healthy volunteers

A publication about formulation and dose selection for further clinical development of a sustained release formulation in the treatment of cryptococcal meningoencephalitis.  This research contributes to combating infectious diseases, and by innovative formulations and optimization of dosing, aim to enhance treatment accessibility and efficacy, ultimately improving lives of those affected by cryptococcal meningoencephalitis.

How we work


Explore our scientific publications.

All publications

Explore our web

Model Informed Drug Development

A quantitative framework to support and inform development program strategies and decisions.

Read more

“Sharing with colleagues is why I love working here”

Sophie Peigné supports clients with expert and strategic advice in pharmacometrics as well as hands-on modeling analyses for compounds in all development phases.

Read more

History of Pharmetheus

Our journey is an exciting one. We began as a start-up that spinned off from Uppsala University. Today, we have grown into a global medium-sized company, adding value to drug development each day.

Read more